Original RtAVM Facebook post
https://www.facebook.com/photo.php?fbid=465114950225186&set=a.414675905269091.96547.414643305272351&type=1&theater
Reposted from
https://www.facebook.com/photo.php?fbid=208726449272029&set=a.144033512407990.42106.144023769075631&type=1
In 2010 in Western Australia, one particular brand of flu vaccine which was recommended to children was found to be connected with a spate of adverse febrile reactions. The investigation is not yet complete, but the reactions are believed to be from a particular batch of the 2010 trivalent influenza vaccine FLUVAX manufactured by CSL. The reactions were from this particular brand of flu vaccine only, and likely due to suboptimal virus splitting or other problems related to the use of deoxycholate as the splitting agent.
More information:
http://theconversation.edu.au/new-theory-on-why-csls-flu-vaccine-caused-febrile-convulsions-in-children-3426
https://ama.com.au/media/possible-cause-identified-2010-flu-vaccine-adverse-events
The batch lot was withdrawn and CSL's Fluvax is still not recommended for children under five. Adults can still receive it though. There are actually 6 seasonal influenza vaccines approved by the TGA for use in Australia as of 2012. Out of the six, there are four: Vaxigrip, Influvac, Fluarix, and Agrippal which are all approved for use in persons aged 6 months and above.
http://www.immunise.health.gov.au/internet/immunise/Publishing.nsf/content/ATAGI-advice-TIV-march2012
Under the Immunise Australia Program influenza vaccination is recommended as part of routine vaccinations for
1. Older Australians
2. Aboriginal and Torres Strait Islanders
3. people over 15 years of age,
4. pregnant women
5. individuals aged 6 months and over with medical conditions predisposing to severe influenza.
http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-influenza
